NEW YORK (Reuters Health) – Active surveillance of prostate cancer, with intervention offered for progressive disease, appears to be safe even for intermediate-risk disease in men over the…
NEW YORK (Reuters Health) – New research confirms that tubular carcinoma (TC) of the breast has an excellent prognosis and goes on to show that outcomes are better…
NEW YORK (Reuters Health) – The initial empiric antimicrobial therapy used to treat septic shock may be the most important determinant of whether a patient will survive to…
NEW YORK (Reuters Health) – In a study of living donor liver transplantations with left side grafts, no significant difference in survival was seen when grafts
NEW YORK (Reuters Health) – In an update to its 2002 guidelines, the US Preventive Services Task Force (USPSTF) is now recommending that mammographic screening for breast cancer…
Marsha Guess, MD, Assistant Professor of Obstetrics, Gynecology and Reproductive Medicine at Yale University, discusses overactive bladder treatment with newer drugs such as trospium chloride, and reminds physicians…
Marsha Guess, MD, Assistant Professor of Obstetrics, Gynecology and Reproductive Medicine at Yale University, discusses altered sexual function in women and a Yale study that is looking at…
NEW YORK (Reuters Health) – After breast-conserving surgery for invasive cancer, mammographic density is a risk factor for local recurrence, particularly in women who don’t undergo radiotherapy, investigators…
NEW YORK (Reuters Health) – In kidney transplant recipients, bringing hemoglobin levels above 125 g/L with erythropoietin may increase mortality, according to a report in the November 6th…
NEW YORK (Reuters Health) – New research suggests that extracorporeal shock-wave therapy (ESWT) is a viable alternative to surgery for long-bone hypertrophic nonunions. “When we examined patients and…